ID   BW5147.G.1.4.OUAR.1
AC   CVCL_4137
AS   CVCL_4136
SY   BW5147.G.1.4.OUA-R.1; BW5147.G.1.4.OUA/R.1
DR   CLO; CLO_0002062
DR   CLO; CLO_0002063
DR   CLDB; cl513
DR   CLDB; cl514
DR   ATCC; CRL-1588
DR   BCRC; 60173
DR   ECACC; 85082302
DR   ECACC; 88100507
DR   JCRB; JCRB9002
DR   Wikidata; Q54798732
RX   PubMed=2365383;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: ~23 hours (Note=Lot 06212000) (JCRB=JCRB9002).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6315 ! BW5147.G.1.4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
CH   CVCL_RW61 ! BW-1100.129
CH   CVCL_B391 ! BW5147(T200-a)5.1
CH   CVCL_6313 ! BW5147(T200-a)5.2
//
RX   PubMed=2365383; DOI=10.1089/hyb.1990.9.285;
RA   Fernandez-Ruiz, Elena
RA   Silva, Augusto
RA   Jotterand-Bellomo, Martine
RT   "Karyotypic analysis of the AKR/J mouse thymoma cell line
RT   BW5147.G.1.4.OUAR.1.";
RL   Hybridoma 9:285-288(1990).
//